Z-2650-2014 Class III Terminated

Recalled by Diagnostica Stago, Inc. — Parsippany, NJ

FDA device recall Z-2650-2014 was initiated by Diagnostica Stago, Inc. on Jul 18, 2014 and is designated Class III. Reason for recall: Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers. The recall status is terminated (terminated Jan 16, 2015). Affected quantity: 514 kits.

Recall details

Product Type
Devices
Report Date
Sep 24, 2014
Initiation Date
Jul 18, 2014
Termination Date
Jan 16, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
514 kits

Product description

Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.

Reason for recall

Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers.

Distribution pattern

Distributed USA (nationwide) and the country of Canada.

Code information

510(k) #K111822, Lot #112366, Part # REF 00311US

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2650-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2650-2014. Report a data issue: hello@regdatalab.com.